Zobrazeno 1 - 10
of 18
pro vyhledávání: '"R. E. De Salamanca"'
Autor:
Ignacio Melero, Irantzu Serrano-Mendioroz, Sandra Hervas-Stubbs, Aizea Morales-Kastresana, Uxua Mancheño, R. E. de Salamanca, Alberto Benito, Ana Sampedro, Antonio Fontanellas, Carmen Unzu
Publikováno v:
Gene therapy. 22(11)
Helper-dependent adenoviral (HDA) vectors constitute excellent gene therapy tools for metabolic liver diseases. We have previously shown that an HDA vector encoding human porphobilinogen deaminase (PBGD) corrects acute intermittent porphyria mice. No
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50cf9499a606e29f3a31c35084778f72
https://pubmed.ncbi.nlm.nih.gov/26125605
https://pubmed.ncbi.nlm.nih.gov/26125605
Autor:
M. Guolo, Alcira Batlle, L. Pataro, M. Biscoglio, C. Franco, Ana María Stella, R. E. De Salamanca, C. Machalinski
Publikováno v:
Nephron Experimental Nephrology. 7:236-241
Among the abnormalities in erythrocyte porphyrin metabolism already described in patients with chronic renal failure on hemodialysis, a decrease in blood aminolevulinate dehydratase activity has been reported, suggesting the presence in uremic plasma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46b8d763b8fabe31e9b5146becbe1b20
https://doi.org/10.1159/000020607
https://doi.org/10.1159/000020607
Publikováno v:
Journal of Enzyme Inhibition. 5:225-233
The action of uroporphyrin I (URO I) on the activity of red cell uroporphyrinogen decarboxylase (URO-D) in the dark and under UV light was studied. Light-dependent-and light-independent inactivation was observed. Both effects increased at increasing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a3d0f71361cab9fcdd95c3acff907a7
https://doi.org/10.3109/14756369109080061
https://doi.org/10.3109/14756369109080061
Publikováno v:
Journal of Enzyme Inhibition. 3:303-310
The action of porphyrins, uroporphyrin I and III (URO I and URO III), pentacarboxylic porphyrin I (PENTA I), coproporphyrin I and III (COPRO I and COPRO III), protoporphyrin IX (PROTO IX) and mesoporphyrin (MESO), on the activity of human erythrocyte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed81ae8fff75d072ba73f08d7c626092
https://doi.org/10.3109/14756369009030379
https://doi.org/10.3109/14756369009030379
Autor:
J.A. Solis-Herruzo, A Gómez de la Cámara, Francisco Colina, Inmaculada Fernández, R. Muñoz, R E de Salamanca, Gregorio Castellano, M J Morán
Publikováno v:
Scandinavian journal of gastroenterology. 38(3)
Porphyria cutanea tarda (PCT) is sometimes associated with hepatitis C virus chronic infection. The aim of this study was to describe the effect of interferon alfa (IFN-alpha) in the treatment of patients with chronic hepatitis C and PCT.We treated a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52155679bf6b25c028b354d358484a6a
https://pubmed.ncbi.nlm.nih.gov/12737448
https://pubmed.ncbi.nlm.nih.gov/12737448
Publikováno v:
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 25(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37a3cd2ba6625b9ec77be3bca6bdf770
https://pubmed.ncbi.nlm.nih.gov/7901137
https://pubmed.ncbi.nlm.nih.gov/7901137
Publikováno v:
British journal of clinical pharmacology. 29(6)
Steady state metabolite/parent drug plasma ratios were measured in 15 epileptic patients on carbamazepine (CBZ) monotherapy and in seven patients treated with CBZ and clobazam (CLB). CBZ plasma concentrations did not differ between the two groups but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bd59625ba06903a627c27822f3c0d8f
https://pubmed.ncbi.nlm.nih.gov/2378792
https://pubmed.ncbi.nlm.nih.gov/2378792
Autor:
R E de Salamanca, A. Fuertes, Gregorio Castellano, Francisco Colina, M.J. Domingo, Inmaculada Fernández, Canga F, R. Muñoz, J.A. Solis
Publikováno v:
Journal of Hepatology. 28:190
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e940a635665c3ee045bf3f70be847cdc
https://doi.org/10.1016/s0168-8278(98)80938-0
https://doi.org/10.1016/s0168-8278(98)80938-0
Publikováno v:
Clinical Science. 58:477-484
1. Erythrocyte uroporphyrinogen decarboxylase activity has been measured in 27 patients with porphyria cutanea tarda, of whom 11 had a family history of overt porphyria cutanea tarda. 2. Eight patients from six families had erythrocyte uroporphyrinog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cd326a9d0cac3af26bb3280270ebc75
https://doi.org/10.1042/cs0580477
https://doi.org/10.1042/cs0580477
Publikováno v:
Revista clinica espanola. 143(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dd680d820a7269442c53605e0d1f9688
https://pubmed.ncbi.nlm.nih.gov/1005797
https://pubmed.ncbi.nlm.nih.gov/1005797